Immuneering Corporation (IMRX) Tops Q1 EPS by 5c

Immuneering Corporation (NASDAQ: IMRX) reported Q1 EPS of ($0.44), $0.05 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Trump: We May Hit Pickaxe Very Soon
• Popular stocks with increasing option volume: MU INTC SPCX MSTR SMCI SNDK AVGO PLTR NFLX LULU HOOD